Superparamagnetic iron oxide nanoparticles in biomedicine: applications and developments in diagnostics and therapy

Standard

Superparamagnetic iron oxide nanoparticles in biomedicine: applications and developments in diagnostics and therapy. / Ittrich, H; Peldschus, K; Raabe, N; Kaul, M; Adam, G.

In: ROFO-FORTSCHR RONTG, Vol. 185, No. 12, 01.12.2013, p. 1149-66.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

APA

Vancouver

Bibtex

@article{40b9926a6a664aab8b17d744e5c42b90,
title = "Superparamagnetic iron oxide nanoparticles in biomedicine: applications and developments in diagnostics and therapy",
abstract = "Superparamagnetic iron oxide nanoparticles (SPIO) can be used to image physiological processes and anatomical, cellular and molecular changes in diseases. The clinical applications range from the imaging of tumors and metastases in the liver, spleen and bone marrow, the imaging of lymph nodes and the CNS, MRA and perfusion imaging to atherosclerotic plaque and thrombosis imaging. New experimental approaches in molecular imaging describe undirected SPIO trapping (passive targeting) in inflammation, tumors and associated macrophages as well as the directed accumulation of SPIO ligands (active targeting) in tumor endothelia and tumor cells, areas of apoptosis, infarction, inflammation and degeneration in cardiovascular and neurological diseases, in atherosclerotic plaques or thrombi. The labeling of stem or immune cells allows the visualization of cell therapies or transplant rejections. The coupling of SPIO to ligands, radio- and/or chemotherapeutics, embedding in carrier systems or activatable smart sensor probes and their externally controlled focusing (physical targeting) enable molecular tumor therapies or the imaging of metabolic and enzymatic processes. Monodisperse SPIO with defined physicochemical and pharmacodynamic properties may improve SPIO-based MRI in the future and as targeted probes in diagnostic magnetic resonance (DMR) using chip-based µNMR may significantly expand the spectrum of in vitro analysis methods for biomarker, pathogens and tumor cells. Magnetic particle imaging (MPI) as a new imaging modality offers new applications for SPIO in cardiovascular, oncological, cellular and molecular diagnostics and therapy.",
keywords = "Animals, Coated Materials, Biocompatible, Ferrosoferric Oxide, Humans, Lymphatic Metastasis, Magnetic Resonance Angiography, Magnetic Resonance Imaging, Magnetic Resonance Spectroscopy, Metabolic Clearance Rate, Molecular Imaging, Molecular Targeted Therapy, Nanoparticles, Neoplasms, Particle Size, Quality Control, Sensitivity and Specificity",
author = "H Ittrich and K Peldschus and N Raabe and M Kaul and G Adam",
note = "{\textcopyright} Georg Thieme Verlag KG Stuttgart · New York.",
year = "2013",
month = dec,
day = "1",
doi = "10.1055/s-0033-1335438",
language = "English",
volume = "185",
pages = "1149--66",
journal = "ROFO-FORTSCHR RONTG",
issn = "1438-9029",
publisher = "Georg Thieme Verlag KG",
number = "12",

}

RIS

TY - JOUR

T1 - Superparamagnetic iron oxide nanoparticles in biomedicine: applications and developments in diagnostics and therapy

AU - Ittrich, H

AU - Peldschus, K

AU - Raabe, N

AU - Kaul, M

AU - Adam, G

N1 - © Georg Thieme Verlag KG Stuttgart · New York.

PY - 2013/12/1

Y1 - 2013/12/1

N2 - Superparamagnetic iron oxide nanoparticles (SPIO) can be used to image physiological processes and anatomical, cellular and molecular changes in diseases. The clinical applications range from the imaging of tumors and metastases in the liver, spleen and bone marrow, the imaging of lymph nodes and the CNS, MRA and perfusion imaging to atherosclerotic plaque and thrombosis imaging. New experimental approaches in molecular imaging describe undirected SPIO trapping (passive targeting) in inflammation, tumors and associated macrophages as well as the directed accumulation of SPIO ligands (active targeting) in tumor endothelia and tumor cells, areas of apoptosis, infarction, inflammation and degeneration in cardiovascular and neurological diseases, in atherosclerotic plaques or thrombi. The labeling of stem or immune cells allows the visualization of cell therapies or transplant rejections. The coupling of SPIO to ligands, radio- and/or chemotherapeutics, embedding in carrier systems or activatable smart sensor probes and their externally controlled focusing (physical targeting) enable molecular tumor therapies or the imaging of metabolic and enzymatic processes. Monodisperse SPIO with defined physicochemical and pharmacodynamic properties may improve SPIO-based MRI in the future and as targeted probes in diagnostic magnetic resonance (DMR) using chip-based µNMR may significantly expand the spectrum of in vitro analysis methods for biomarker, pathogens and tumor cells. Magnetic particle imaging (MPI) as a new imaging modality offers new applications for SPIO in cardiovascular, oncological, cellular and molecular diagnostics and therapy.

AB - Superparamagnetic iron oxide nanoparticles (SPIO) can be used to image physiological processes and anatomical, cellular and molecular changes in diseases. The clinical applications range from the imaging of tumors and metastases in the liver, spleen and bone marrow, the imaging of lymph nodes and the CNS, MRA and perfusion imaging to atherosclerotic plaque and thrombosis imaging. New experimental approaches in molecular imaging describe undirected SPIO trapping (passive targeting) in inflammation, tumors and associated macrophages as well as the directed accumulation of SPIO ligands (active targeting) in tumor endothelia and tumor cells, areas of apoptosis, infarction, inflammation and degeneration in cardiovascular and neurological diseases, in atherosclerotic plaques or thrombi. The labeling of stem or immune cells allows the visualization of cell therapies or transplant rejections. The coupling of SPIO to ligands, radio- and/or chemotherapeutics, embedding in carrier systems or activatable smart sensor probes and their externally controlled focusing (physical targeting) enable molecular tumor therapies or the imaging of metabolic and enzymatic processes. Monodisperse SPIO with defined physicochemical and pharmacodynamic properties may improve SPIO-based MRI in the future and as targeted probes in diagnostic magnetic resonance (DMR) using chip-based µNMR may significantly expand the spectrum of in vitro analysis methods for biomarker, pathogens and tumor cells. Magnetic particle imaging (MPI) as a new imaging modality offers new applications for SPIO in cardiovascular, oncological, cellular and molecular diagnostics and therapy.

KW - Animals

KW - Coated Materials, Biocompatible

KW - Ferrosoferric Oxide

KW - Humans

KW - Lymphatic Metastasis

KW - Magnetic Resonance Angiography

KW - Magnetic Resonance Imaging

KW - Magnetic Resonance Spectroscopy

KW - Metabolic Clearance Rate

KW - Molecular Imaging

KW - Molecular Targeted Therapy

KW - Nanoparticles

KW - Neoplasms

KW - Particle Size

KW - Quality Control

KW - Sensitivity and Specificity

U2 - 10.1055/s-0033-1335438

DO - 10.1055/s-0033-1335438

M3 - SCORING: Journal article

C2 - 24008761

VL - 185

SP - 1149

EP - 1166

JO - ROFO-FORTSCHR RONTG

JF - ROFO-FORTSCHR RONTG

SN - 1438-9029

IS - 12

ER -